🟢 Syncom Formulations is trading 10.5% up with no confirmed catalyst

Syncom Formulations is trading 10.45% up at ₹24.52, with no confirmed company-specific catalyst identified for the September 29 rise.

• The move follows a sharp September 28 session, when shares closed at ₹22.20, up 10.72%, amid unusually heavy trading volume.
• The latest listed company filing before the move was a September 26 notice that promoters voluntarily waived their final dividend; available sources do not establish a link to the rally.